Cedar Brook Financial Partners’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-21,708
Closed -$217K – 267
2024
Q1
$217K Buy
21,708
+1,574
+8% +$13.8K 0.04% 402
2023
Q4
$150K Buy
20,134
+730
+4% +$4.85K 0.03% 409
2023
Q3
$154K Buy
19,404
+3,494
+22% +$22K 0.04% 365
2023
Q2
$88.1K Buy
15,910
+1,089
+7% +$5.97K 0.02% 397
2023
Q1
$84.3K Buy
14,821
+1,712
+13% +$11.3K 0.02% 381
2022
Q4
$91.6K Buy
13,109
+1,534
+13% +$15.8K 0.03% 363
2022
Q3
$103K Buy
11,575
+1,141
+11% +$13.2K 0.03% 340
2022
Q2
$108K Buy
+10,434
New +$155K 0.03% 334

Other funds holding MSOS

Cedar Brook Financial Partners's MSOS Position: Q2 2024 in Review

Cedar Brook Financial Partners sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q2 2024, closing a stake of 21,708 shares — an estimated $217K sold.

Cedar Brook Financial Partners first reported a position in MSOS in Q2 2022 and held it in 8 quarters. The position peaked at $217K in Q1 2024. 188 funds tracked by Wall St. Rank hold MSOS as of Q2 2024.

  • Cedar Brook Financial Partners reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q2 2024 after selling out during the quarter.
  • Cedar Brook Financial Partners sold 21,708 AdvisorShares Pure US Cannabis ETF shares in Q2 2024, an estimated $217K.
  • Cedar Brook Financial Partners first reported a position in AdvisorShares Pure US Cannabis ETF in Q2 2022 and held it in 8 quarters.
  • Cedar Brook Financial Partners's AdvisorShares Pure US Cannabis ETF position peaked at $217K in Q1 2024.
  • 188 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2024.

Based on Cedar Brook Financial Partners's 13F filing for Q2 2024, filed 15 Jul 2024.